Contraindications and Precautions Do NOT use AOD-9604 if you: Are pregnant, trying to conceive, or breastfeeding (no safety data in pregnancy/lactation) Have active cancer or history of malignancy (peptide effects on existing cancer unknown) Are under 18 years of age (pediatric safety not established) Have known hypersensitivity to peptides or benzyl alcohol (in bacteriostatic water) Have severe kidney or liver disease without physician clearance Use with caution and enhanced monitoring if you have: Diabetes or glucose metabolism disorders (monitor blood sugar closely despite no expected impact) Cardiovascular disease (comprehensive cardiac evaluation recommended) Thyroid disorders (monitor thyroid function during therapy) History of migraines (may increase headache frequency in susceptible individuals) Drug Interactions Limited formal drug interaction studies exist for AOD-9604
Many people go there for quality, yet affordable healthcare, including gastric bypass surgery
[6] The most defensible description is that AOD9604 was associated with beta-3-adrenergic-receptor-related adaptations in mouse adipose tissue, while the direct molecular target responsible for the reported metabolic effects remained unresolved
The GLOW peptide blend contains three peptides in a fixed 50/10/10 mg ratio: GHK-Cu Builds new collagen and clears damaged tissue at the same time. Most collagen interventions only do the first
If you have the MTHFR polymorphism, you could benefit from the active form of folate (5-MTHF or methylfolate), which may be more bioavailable
